|
May 15
|
Novo Nordisk Bets Up to $600 Million on Ozempic 2.0. Here's Why the Stock Is a Buy.
|
|
May 15
|
PRESS DIGEST- Financial Times - May 15
|
|
May 14
|
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
|
|
May 14
|
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
|
|
May 14
|
European Equities Close Mostly Higher in Tuesday Trading; Anglo American Plans Overhaul in Face of BHP Takeover Bid
|
|
May 14
|
Novo Nordisk's Wegovy Reduces Cardiac Events, Sustains Weight Loss, New Analysis Shows
|
|
May 14
|
Ozempic Maker Novo Sells $5 Billion in Bonds to Fund Deal
|
|
May 14
|
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
|
|
May 14
|
2 Top Pharma Stocks That Just Keep Getting Better and Better
|
|
May 14
|
Is Eli Lilly's Latest Deal a Gamechanger?
|
|
May 14
|
UPDATE 3-Wegovy users keep weight off for four years, Novo Nordisk study says
|
|
May 14
|
Novo Nordisk shares positive results from Phase IIIa trial of haemophilia A drug
|
|
May 13
|
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
|
|
May 13
|
Novo Nordisk's Hemophilia Candidate Can Prevent Bleeding Episodes Effectively, Regardless Of Dosing Frequency
|
|
May 13
|
Sector Update: Health Care Stocks Mixed Late Afternoon
|
|
May 13
|
Remembering Quant King Jim Simons
|
|
May 13
|
Update: Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
|
|
May 13
|
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
|
|
May 13
|
UPDATE 2-Denmark faces Wegovy shortage due to rising demand
|
|
May 13
|
‘Outrageously’ expensive Ozempic should be cheaper, says Bernie Sanders
|